Use of Arterial Transfer Functions for the Derivation of Central Aortic Waveform Characteristics in Subjects With Type 2 Diabetes and Cardiovascular Disease

Hope, Sarah A.; Tay, David B.; Meredith, Ian T.; Cameron, James D.
March 2004
Diabetes Care;Mar2004, Vol. 27 Issue 3, p746
Academic Journal
Optimal blood pressure control in subjects with diabetes reduces cardiovascular complications. There is theoretical benefit in the assessment of central aortic waveforms including the augmentation index, which is taken as a putative index of stiffness. Transfer functions may be used to reconstruct aortic from radial pressure waveforms; however, a single generalized transfer function may not be appropriate for all patients. We aimed to evaluate the technique in subjects with diabetes. There was no difference between groups in measured central pressures. The error in generalized transfer function-derived systolic pressure was greater in individuals with diabetes (6 ± 7 mmHg) (mean ± SD) than without diabetes (2 ± 8 mmHg) (P < 0.05). Errors in other parameters were no different. The diabetes-specific transfer function reduced the error in derived systolic pressure to 0 ± 7 mmHg in individuals with diabetes—no different than that with the generalized transfer function in individuals without diabetes. The central augmentation index reconstructed by either transfer function was unrelated to that directly measured. A generalized transfer function is inappropriate for the derivation of central waveforms in subjects with type 2 diabetes. Errors in subjects with diabetes might be reduced with a diabetes-specific transfer function.


Related Articles

  • INVEST: Systolic BP control not associated with improved CV outcomes in patients with CAD, diabetes.  // Cardiology Today;Sep2010, Vol. 13 Issue 9, p29 

    The article focuses on the International Verapamil SR-Trandolapril Study (INVEST) which found that there is no link between tight control of systolic blood pressure (BP) in individuals suffering from diabetes and coronary artery disease (CAD), and improved cardiovascular (CV) outcomes.

  • British Hypertension Society guidelines 2004. Mead, Mike // Update;3/4/2004, Vol. 68 Issue 4, p157 

    The latest British Hypertension Society Guidelines build on the previous 1999 guidelines without radical change. They align with European Society guidelines for the classification of hypertension, with mild disease defined as a blood pressure of 140-159/90-99 mmHg, moderate hypertension as...

  • GP Business: Registrar Update - Diabetes - part three. Newson, Louise // GP: General Practitioner;9/6/2004, p43 

    The article focuses on several issues related to diabetes. The management of diabetes is not just about managing patients' glucose levels. In view of the high risk of cardiovascular disease in people with diabetes, particularly those with type-2 diabetes, the careful management of other...

  • Can a chronic care model collaborative reduce heart disease risk in patients with diabetes? Vargas, Roberto B.; Mangione, Carol M.; Asch, Steven; Keesey, Joan; Rosen, Mayde; Schonlau, Matthias; Keeler, Emmett B. // JGIM: Journal of General Internal Medicine;Feb2007, Vol. 22 Issue 2, p215 

    Background: There is a need to identify effective practical interventions to decrease cardiovascular disease risk in patients with diabetes.Objective: We examine the impact of participation in a collaborative implementing the chronic care model (CCM) on the reduction of...

  • Predictors of new-onset diabetes mellitus in hypertensive patients: the VALUE trial. Aksnes, T A; Kjeldsen, S E; Rostrup, M; Störset, Ö; Hua, T A; Julius, S // Journal of Human Hypertension;Aug2008, Vol. 22 Issue 8, p520 

    Diabetes mellitus often develops in patients with hypertension. We investigated predictors of diabetes mellitus development in hypertensives at risk of developing the disease in the VALUE trial population. Among the 9995 non-diabetic hypertensive patients at baseline, 1298 patients developed...

  • Aiming for lower than 140/90 mm Hg. Saunders, Carol S. // Patient Care for the Nurse Practitioner;Apr2000, Vol. 3 Issue 4, p60 

    Explains how to individualize treatment for hypertensive and diabetic patients to meet their blood pressure goals. When to start an antihypertensive drug therapy; How to maximize the antihypertensive effects and minimize adverse metabolic effects when prescribing diuretics; Importance of...

  • GP Business: Hypertension - part two. Newson, Louise // GP: General Practitioner;6/21/2004, p49 

    The latest British Hypertension Society guidelines are similar in many respects to the previous guidelines. They align with European Society guidelines for the classification of hypertension. Mild disease is defined as a blood pressure of 140-159/90-99 mmHg, moderate hypertension as...

  • Controlling hypertension in diabetes. Morrison, Errol Y. St. A. // Caribbean Health;Oct1999, Vol. 2 Issue 3, p20 

    The article presents a number of studies about hypertension in patients with diabetes mellitus. The Hypertension Optimal Treatment (HOT) study indicated that diabetic patients maintaining a diastolic target of 80 mmHg had half as many major cardiovascular events as those with a value of 90mmHg....

  • Prognostic Value of Blood Pressure Variability and Average Blood Pressure Levels in Patients With Hypertension and Diabetes. PARATI, GIANFRANCO; OCHOA, JUAN EUGENIO; SALVI, PAOLO; LOMBARDI, CAROLINA; BILO, GRZEGORZ // Diabetes Care;Aug2013 Supplement, Vol. 36 Issue S2, pS312 

    The article examines research papers on the prognostic importance of blood pressure (BP) mean levels and of BP variability estimates in patients with hypertension and diabetes. It is stated that patients with diabetes and elevated BP levels are at higher risk for cardiovascular (CV) events...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics